Cart
sales@molnova.com
Lomitapide Mesylate
CAS No. 202914-84-9
Lomitapide Mesylate( —— )
Catalog No. M13157 CAS No. 202914-84-9
Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 132 | In Stock |
|
| 50MG | 214 | In Stock |
|
| 100MG | 322 | In Stock |
|
| 200MG | 475 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLomitapide Mesylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionLomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
-
DescriptionLomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetCETP
-
RecptorMTP
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number202914-84-9
-
Formula Weight789.83
-
Molecular FormulaC40H41F6N3O5S
-
Purity>98% (HPLC)
-
SolubilityEthanol: 100 mg/mL (126.6 mM); DMSO: 100 mg/mL (126.6 mM)
-
SMILESCS(O)(=O)=O.FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=CC=CC=C2C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Davis KA, Miyares MA. Am J Health Syst Pharm. 2014 Jun 15;71(12):1001-8.
molnova catalog
related products
-
CKD-519
CKD-519 (Rocacetrapib, CKD519) is a potent, selective cholesteryl ester transfer protein (CETP) inhibitor, inhibits the CETP-mediated transfer of cholesteryl ester in human serum with IC50 of 2.3 nM.
-
Lomitapide Mesylate
Lomitapide Mesylate is a potent microsomal triglyceride transfer protein (MTP) inhibitor, used in the treatment of familial hypercholesterolemia.
-
Granotapide
Granotapide is a microsomal triglyceride transfer protein (MTP) inhibitor that treats and rather prevents atherosclerosis, coronary artery disease, metabolic syndrome, obesity, diabetes mellitus, prediabetes mellitus, and hypertension.
